skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Elsevier ScienceDirect Journals remover assunto: Pharmacology. Drug Treatments remover Middle Aged remover Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

Viale, G. ; Slaets, L. ; Bogaerts, J. ; Rutgers, E. ; van't Veer, L. ; Piccart-Gebhart, M.J. ; de Snoo, F.A. ; Stork-Sloots, L. ; Russo, L. ; Dell'Orto, P. ; van den Akker, J. ; Glas, A. ; Cardoso, F.

Annals of oncology, 2014-04, Vol.25 (4), p.816-823 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial

de Azambuja, E. ; Zardavas, D. ; Lemort, M. ; Rossari, J. ; Moulin, C. ; Buttice, A. ; D'Hondt, V. ; Lebrun, F. ; Lalami, Y. ; Cardoso, F. ; Sotiriou, C. ; Gil, T. ; Devriendt, D. ; Paesmans, M. ; Piccart-Gebhart, M. ; Awada, A.

Annals of oncology, 2013-12, Vol.24 (12), p.2985-2989 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Risk estimations and treatment decisions in early stage breast cancer: Agreement among oncologists and the impact of the 70-gene signature
Risk estimations and treatment decisions in early stage breast cancer: Agreement among oncologists and the impact of the 70-gene signature
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk estimations and treatment decisions in early stage breast cancer: Agreement among oncologists and the impact of the 70-gene signature

Drukker, C.A ; van den Hout, H.C ; Sonke, G.S ; Brain, E ; Bonnefoi, H ; Cardoso, F ; Goldhirsch, A ; Harbeck, N ; Honkoop, A.H ; Koornstra, R.H.T ; van Laarhoven, H.W.M ; Portielje, J.E.A ; Schneeweiss, A ; Smorenburg, C.H ; Stouthard, J ; Linn, S.C ; Schmidt, M.K

European journal of cancer (1990), 2014-04, Vol.50 (6), p.1045-1054 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial
Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial

Mook, S ; Bonnefoi, H ; Pruneri, G ; Larsimont, D ; Jaskiewicz, J ; Sabadell, M.D ; MacGrogan, G ; van’t Veer, L.J ; Cardoso, F ; Rutgers, E.J

European Journal of Cancer, 2009-05, Vol.45 (7), p.1201-1208 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients

Bernard-Marty, C. ; Mano, M. ; Paesmans, M. ; Accettura, C. ; Munoz-Bermeo, R. ; Richard, T. ; Kleiber, K. ; Cardoso, F. ; Lobelle, J. P. ; Larsimont, D. ; Piccart, M. J. ; Di Leo, A.

Annals of oncology, 2003-05, Vol.14 (5), p.693-698 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
6
Current perspectives of epothilones in breast cancer
Current perspectives of epothilones in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Current perspectives of epothilones in breast cancer

Cardoso, Fatima ; de Azambuja, Evandro ; Lago, Lissandra Dal

European journal of cancer (1990), 2008-02, Vol.44 (3), p.341-352 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions
Material Type:
Artigo 		Adicionar ao Meu Espaço

The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions

Ferreira Filho, A. F. ; Di Leo, A. ; Paesmans, M. ; Beauduin, M. ; Vindevoghel, A. ; Michel, J. ; Focan, C. ; Awada, A. ; Cardoso, F. ; Dolci, S. ; Bartholomeus, S. ; Piccart, M. J.

Annals of oncology, 2002-03, Vol.13 (3), p.416-421 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
8
Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer
Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer

Cardoso, Fatima ; Di Leo, Angelo ; Piccart, Martine J.

Cancer treatment reviews, 2002-12, Vol.28 (6), p.275-290 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension
Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension

Salles, Gil F ; Cardoso, Claudia R.L ; Fiszman, Roberto ; Muxfeldt, Elizabeth S

Atherosclerosis, 2011-05, Vol.216 (1), p.199-204 [Periódico revisado por pares]

Amsterdam: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
10
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies

von Mehren, M. ; Schilder, R.J. ; Cheng, J.D. ; Temmer, E. ; Cardoso, T.M. ; Renshaw, F.G. ; Bayever, E. ; Zannikos, P. ; Yuan, Z. ; Cohen, R.B.

Annals of oncology, 2008-10, Vol.19 (10), p.1802-1809 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.